252 related articles for article (PubMed ID: 37626856)
1. Glucocorticoid Receptor Regulates and Interacts with LEDGF/p75 to Promote Docetaxel Resistance in Prostate Cancer Cells.
Sanchez-Hernandez ES; Ochoa PT; Suzuki T; Ortiz-Hernandez GL; Unternaehrer JJ; Alkashgari HR; Diaz Osterman CJ; Martinez SR; Chen Z; Kremsky I; Wang C; Casiano CA
Cells; 2023 Aug; 12(16):. PubMed ID: 37626856
[TBL] [Abstract][Full Text] [Related]
2. The LEDGF/p75 Integrase Binding Domain Interactome Contributes to the Survival, Clonogenicity, and Tumorsphere Formation of Docetaxel-Resistant Prostate Cancer Cells.
Ortiz-Hernandez GL; Sanchez-Hernandez ES; Ochoa PT; Elix CC; Alkashgari HR; McMullen JRW; Soto U; Martinez SR; Diaz Osterman CJ; Mahler M; Roy S; Casiano CA
Cells; 2021 Oct; 10(10):. PubMed ID: 34685704
[TBL] [Abstract][Full Text] [Related]
3. Targeting the stress oncoprotein LEDGF/p75 to sensitize chemoresistant prostate cancer cells to taxanes.
Ríos-Colón L; Cajigas-Du Ross CK; Basu A; Elix C; Alicea-Polanco I; Sanchez TW; Radhakrishnan V; Chen CS; Casiano CA
Oncotarget; 2017 Apr; 8(15):24915-24931. PubMed ID: 28212536
[TBL] [Abstract][Full Text] [Related]
4. Glucocorticoid Receptor and β-Catenin Interact in Prostate Cancer Cells and Their Co-Inhibition Attenuates Tumorsphere Formation, Stemness, and Docetaxel Resistance.
Martinez SR; Elix CC; Ochoa PT; Sanchez-Hernandez ES; Alkashgari HR; Ortiz-Hernandez GL; Zhang L; Casiano CA
Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108293
[TBL] [Abstract][Full Text] [Related]
5. Glucocorticoids Induce Stress Oncoproteins Associated with Therapy-Resistance in African American and European American Prostate Cancer Cells.
Woods-Burnham L; Cajigas-Du Ross CK; Love A; Basu A; Sanchez-Hernandez ES; Martinez SR; Ortiz-Hernández GL; Stiel L; Durán AM; Wilson C; Montgomery S; Roy S; Casiano CA
Sci Rep; 2018 Oct; 8(1):15063. PubMed ID: 30305646
[TBL] [Abstract][Full Text] [Related]
6. LEDGF/p75 Overexpression Attenuates Oxidative Stress-Induced Necrosis and Upregulates the Oxidoreductase ERP57/PDIA3/GRP58 in Prostate Cancer.
Basu A; Cajigas-Du Ross CK; Rios-Colon L; Mediavilla-Varela M; Daniels-Wells TR; Leoh LS; Rojas H; Banerjee H; Martinez SR; Acevedo-Martinez S; Casiano CA
PLoS One; 2016; 11(1):e0146549. PubMed ID: 26771192
[TBL] [Abstract][Full Text] [Related]
7. Pathway specific gene expression profiling reveals oxidative stress genes potentially regulated by transcription co-activator LEDGF/p75 in prostate cancer cells.
Basu A; Drame A; Muñoz R; Gijsbers R; Debyser Z; De Leon M; Casiano CA
Prostate; 2012 May; 72(6):597-611. PubMed ID: 21796653
[TBL] [Abstract][Full Text] [Related]
8. Docetaxel-induced prostate cancer cell death involves concomitant activation of caspase and lysosomal pathways and is attenuated by LEDGF/p75.
Mediavilla-Varela M; Pacheco FJ; Almaguel F; Perez J; Sahakian E; Daniels TR; Leoh LS; Padilla A; Wall NR; Lilly MB; De Leon M; Casiano CA
Mol Cancer; 2009 Aug; 8():68. PubMed ID: 19715609
[TBL] [Abstract][Full Text] [Related]
9. Glucocorticoid receptor antagonism reverts docetaxel resistance in human prostate cancer.
Kroon J; Puhr M; Buijs JT; van der Horst G; Hemmer DM; Marijt KA; Hwang MS; Masood M; Grimm S; Storm G; Metselaar JM; Meijer OC; Culig Z; van der Pluijm G
Endocr Relat Cancer; 2016 Jan; 23(1):35-45. PubMed ID: 26483423
[TBL] [Abstract][Full Text] [Related]
10. The stress oncoprotein LEDGF/p75 interacts with the methyl CpG binding protein MeCP2 and influences its transcriptional activity.
Leoh LS; van Heertum B; De Rijck J; Filippova M; Rios-Colon L; Basu A; Martinez SR; Tungteakkhun SS; Filippov V; Christ F; De Leon M; Debyser Z; Casiano CA
Mol Cancer Res; 2012 Mar; 10(3):378-91. PubMed ID: 22275515
[TBL] [Abstract][Full Text] [Related]
11. Antinuclear autoantibodies in prostate cancer: immunity to LEDGF/p75, a survival protein highly expressed in prostate tumors and cleaved during apoptosis.
Daniels T; Zhang J; Gutierrez I; Elliot ML; Yamada B; Heeb MJ; Sheets SM; Wu X; Casiano CA
Prostate; 2005 Jan; 62(1):14-26. PubMed ID: 15389814
[TBL] [Abstract][Full Text] [Related]
12. Exosomal circRNA Scm-like with four malignant brain tumor domains 2 (circ-SFMBT2) enhances the docetaxel resistance of prostate cancer via the microRNA-136-5p/tribbles homolog 1 pathway.
Tan X; Song X; Fan B; Li M; Zhang A; Pei L
Anticancer Drugs; 2022 Oct; 33(9):871-882. PubMed ID: 36136987
[TBL] [Abstract][Full Text] [Related]
13. Expression of the stress response oncoprotein LEDGF/p75 in human cancer: a study of 21 tumor types.
Basu A; Rojas H; Banerjee H; Cabrera IB; Perez KY; De León M; Casiano CA
PLoS One; 2012; 7(1):e30132. PubMed ID: 22276150
[TBL] [Abstract][Full Text] [Related]
14. LEDGF/p75 TATA-less promoter is driven by the transcription factor Sp1.
Desfarges S; Abderrahmani A; Hernàndez-Novoa B; Munoz M; Ciuffi A
J Mol Biol; 2011 Nov; 414(2):177-93. PubMed ID: 22019592
[TBL] [Abstract][Full Text] [Related]
15. Alternative splicing and caspase-mediated cleavage generate antagonistic variants of the stress oncoprotein LEDGF/p75.
Brown-Bryan TA; Leoh LS; Ganapathy V; Pacheco FJ; Mediavilla-Varela M; Filippova M; Linkhart TA; Gijsbers R; Debyser Z; Casiano CA
Mol Cancer Res; 2008 Aug; 6(8):1293-307. PubMed ID: 18708362
[TBL] [Abstract][Full Text] [Related]
16. Autoantibodies to lens epithelium-derived growth factor/transcription co-activator P75 (LEDGF/P75) in children with chronic nonspecific complaints and with positive antinuclear antibodies.
Kuwabara N; Itoh Y; Igarshi T; Fukunaga Y
Autoimmunity; 2009 Sep; 42(6):492-6. PubMed ID: 19657776
[TBL] [Abstract][Full Text] [Related]
17. LEDGF/p75-mediated chemoresistance of mixed-lineage leukemia involves cell survival pathways and super enhancer activators.
Canella A; Van Belle S; Brouns T; Nigita G; Carlon MS; Christ F; Debyser Z
Cancer Gene Ther; 2022 Feb; 29(2):133-140. PubMed ID: 33795806
[TBL] [Abstract][Full Text] [Related]
18. Long noncoding RNA MALAT1 enhances the docetaxel resistance of prostate cancer cells via miR-145-5p-mediated regulation of AKAP12.
Xue D; Lu H; Xu HY; Zhou CX; He XZ
J Cell Mol Med; 2018 Jun; 22(6):3223-3237. PubMed ID: 29633510
[TBL] [Abstract][Full Text] [Related]
19. Over-Expression of LEDGF/p75 in HEp-2 Cells Enhances Autoimmune IgG Response in Patients with Benign Prostatic Hyperplasia-A Novel Diagnostic Approach with Therapeutic Consequence?
Liedtke V; Rose L; Hiemann R; Nasser A; Rödiger S; Bonaventura A; Winkler L; Sowa M; Stöckle M; Schierack P; Junker K; Roggenbuck D
Int J Mol Sci; 2023 Mar; 24(7):. PubMed ID: 37047137
[TBL] [Abstract][Full Text] [Related]
20. Transcriptional protein Sp1 regulates LEDGF transcription by directly interacting with its cis-elements in GC-rich region of TATA-less gene promoter.
Singh DP; Bhargavan B; Chhunchha B; Kubo E; Kumar A; Fatma N
PLoS One; 2012; 7(5):e37012. PubMed ID: 22615874
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]